Cargando…

Ivermectin Should Not Be Recommended to Treat Severe Acute Respiratory Syndrome 2 Infection

Detalles Bibliográficos
Autores principales:	Boven, A G, Kenyon, C, Colebunders, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499933/ https://www.ncbi.nlm.nih.gov/pubmed/34984211 http://dx.doi.org/10.1093/ofid/ofab456

Ejemplares similares

Variability of severe acute respiratory syndrome coronavirus 2 infection in children and adults
por: Verma, Geetika, et al.
Publicado: (2023)

Hepatitis B virus reactivation during severe acute respiratory syndrome coronavirus-2 infection
por: Tyng-Yuan, Jang
Publicado: (2023)

Prophylactic Role of Ivermectin in Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers
por: Behera, Priyamadhaba, et al.
Publicado: (2021)

Radiological Findings in Severe Acute Respiratory Syndrome
por: Ahuja, A
Publicado: (2003)

Balneotherapy in the era of COVID-19: should it be recommended or not?
por: Guvener, Orhan
Publicado: (2020)

Aplastic anemia following the severe acute respiratory syndrome coronavirus‐2 vaccine
por: Babakhanlou, Rodrick, et al.
Publicado: (2022)

Pool Size Selection When Testing for Severe Acute Respiratory Syndrome Coronavirus 2
por: Bilder, Christopher R, et al.
Publicado: (2020)

Standard Dose Ivermectin for COVID-19
por: Buonfrate, Dora, et al.
Publicado: (2021)

Severe Acute Kidney Injury in Patients with COVID-19 and Acute Respiratory Distress Syndrome
por: Chaibi, Khalil, et al.
Publicado: (2020)

Syndemic responses to COVID-19 should include an ecological dimension
por: Kenyon, Chris
Publicado: (2020)

Ivermectin in COVID-19. Argumentun ad ignorantiam?()
por: Carlosama-Rosero, Y.
Publicado: (2020)

Severe Acute Respiratory Distress Syndrome after Bilateral Total Knee Replacement
por: Ma, Lu-Lu, et al.
Publicado: (2015)

Impacts of transmembrane serine protease 4 expression on susceptibility to severe acute respiratory syndrome coronavirus 2
por: Tan, Qi, et al.
Publicado: (2023)

The new Surviving Sepsis Campaign recommendations on glucose control should be reconsidered
por: Schultz, Marcus J., et al.
Publicado: (2008)

Why we should not recommend or offer fluvoxamine to COVID-19 patients?
por: Trkulja, Vladimir
Publicado: (2022)

Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?
por: Amit, Moran, et al.
Publicado: (2020)

Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?()
por: López Reboiro, M.L., et al.
Publicado: (2020)

Integrating Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Severe Acute Respiratory Distress Syndrome
por: Shekar, Kiran, et al.
Publicado: (2019)

OPV-like poliovirus type 1 detection in patients with severe acute respiratory syndrome
por: Shen, H., et al.
Publicado: (2012)

Staying Awake in Severe Acute Respiratory Distress Syndrome: A Perspective on Immunocompromised Patients
por: Stahl, Klaus, et al.
Publicado: (2021)

Messenger RNA vaccines and neutralizing anti–severe acute respiratory syndrome coronavirus 2 antibodies in patients with immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Eliciting History of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Diagnosing Interstitial Lung Disease during the Coronavirus Disease 2019 Pandemic
por: Stuewe, Elena, et al.
Publicado: (2021)

Evidence-based intraoperative infection control measures plus feedback are associated with attenuation of severe acute respiratory syndrome coronavirus-2 detection in operating rooms
por: Loftus, Randy W., et al.
Publicado: (2022)

Letter to the Editor concerning A study on infectivity of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) carriers by Gao et al
por: Silverman, Erin P., et al.
Publicado: (2022)

Severe Acute Cor Pulmonale in Patients with COVID-19 Acute Respiratory Distress Syndrome: Caution with Left Turn
por: Evrard, Bruno, et al.
Publicado: (2022)

Body mass index and acute respiratory distress severity in patients with and without SARS-CoV-2 infection
por: Chiumello, Davide, et al.
Publicado: (2020)

Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19
por: Temple, Courtney, et al.
Publicado: (2021)

Should We Monitor Pulsus Paradoxus via Pulse Oximetry in Patients with COVID-19 and Acute Respiratory Failure?
por: Michard, Frederic, et al.
Publicado: (2020)

Finite Element Modeling of Pulmonary Mechanics in Severe Acute Respiratory Distress Syndrome: Explaining the Inclination Angle?
por: Oppersma, Eline, et al.
Publicado: (2022)

Presumed respiratory syncytial virus and severe acute respiratory syndrome coronavirus-2 co-infection in a critically ill infant: Diagnostic uncertainty and emergency management
por: Burstein, Brett, et al.
Publicado: (2020)

The attributable mortality of acute respiratory distress syndrome
por: Auriemma, Catherine L., et al.
Publicado: (2020)

Reply to Shekar and Schmidt: Integrating Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Severe Acute Respiratory Distress Syndrome
por: Araos, Joaquin, et al.
Publicado: (2019)

Improving Outcomes for Patients With Severe COVID-19 Acute Respiratory Distress Syndrome Supported With Extracorporeal Membrane Oxygenation
por: James, Les, et al.
Publicado: (2023)

Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
por: Chuang, Tzu-Yi, et al.
Publicado: (2021)

Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use
por: Hagiya, Hideharu, et al.
Publicado: (2021)

Acute respiratory distress syndrome secondary to human metapneumovirus infection in a young healthy adult
por: Contentin, Laetitia, et al.
Publicado: (2013)

Comment on “COVID-19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities”
por: Cai, Jianghui, et al.
Publicado: (2021)

Efficacy of anti‐severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation
por: Garnier, Alice, et al.
Publicado: (2022)

Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome
por: Simonson, Oscar E., et al.
Publicado: (2020)

Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?
por: Marchese, Anna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ge3lf6bq84bsrpf2do1pvkvce7